175 related articles for article (PubMed ID: 30646583)
1. c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.
Leonetti E; Gesualdi L; Scheri KC; Dinicola S; Fattore L; Masiello MG; Cucina A; Mancini R; Bizzarri M; Ricci G; Catizone A
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646583
[No Abstract] [Full Text] [Related]
2. The PI3K/AKT Pathway Is Activated by HGF in NT2D1 Non-Seminoma Cells and Has a Role in the Modulation of Their Malignant Behavior.
Gesualdi L; Leonetti E; Cucina A; Scicchitano BM; Sorrentino S; Tarsitano MG; Isidori A; Bizzarri M; Filippini A; Riccioli A; Cammarota M; Gigantino V; Ricci G; Catizone A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212946
[TBL] [Abstract][Full Text] [Related]
3. ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.
Gesualdi L; Berardini M; Scicchitano BM; Castaldo C; Bizzarri M; Filippini A; Riccioli A; Schiraldi C; Ferranti F; Liguoro D; Mancini R; Ricci G; Catizone A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509533
[TBL] [Abstract][Full Text] [Related]
4. c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors.
Scheri KC; Leonetti E; Laino L; Gigantino V; Gesualdi L; Grammatico P; Bizzari M; Franco R; Oosterhuis JW; Stoop H; Looijenga LHJ; Ricci G; Catizone A
Oncotarget; 2018 Aug; 9(61):31842-31860. PubMed ID: 30159127
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
Li Y; Fan X; Goodwin CR; Laterra J; Xia S
BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
[TBL] [Abstract][Full Text] [Related]
6. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
[TBL] [Abstract][Full Text] [Related]
7. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
Herynk MH; Zhang J; Parikh NU; Gallick GE
J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
[TBL] [Abstract][Full Text] [Related]
8. Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells.
Qian LW; Mizumoto K; Inadome N; Nagai E; Sato N; Matsumoto K; Nakamura T; Tanaka M
Int J Cancer; 2003 May; 104(5):542-9. PubMed ID: 12594808
[TBL] [Abstract][Full Text] [Related]
9. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
10. TCam-2 seminoma cell line exhibits characteristic foetal germ cell responses to TGF-beta ligands and retinoic acid.
Young JC; Jaiprakash A; Mithraprabhu S; Itman C; Kitazawa R; Looijenga LH; Loveland KL
Int J Androl; 2011 Aug; 34(4 Pt 2):e204-17. PubMed ID: 21668453
[TBL] [Abstract][Full Text] [Related]
11. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
12. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
13. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
14. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1.
Pongchairerk U; Guan JL; Leardkamolkarn V
World J Gastroenterol; 2005 Oct; 11(37):5845-52. PubMed ID: 16270396
[TBL] [Abstract][Full Text] [Related]
16. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
[TBL] [Abstract][Full Text] [Related]
17. Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma.
Bouskine A; Vega A; Nebout M; Benahmed M; Fénichel P
Int J Androl; 2010 Feb; 33(1):54-63. PubMed ID: 19226408
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma.
Yu G; Wang Z; Zeng S; Liu S; Zhu C; Xu R; Liu RE
Biomed Res Int; 2019; 2019():9053295. PubMed ID: 30886866
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
Matsushita A; Götze T; Korc M
Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
